-
公开(公告)号：US11001557B2
公开(公告)日：2021-05-11
申请号：US16479081
申请日：2018-01-16
IPC分类号： C07D215/44 , A61P31/12 , C07D401/12 , C07D413/12 , C07D417/12
摘要： The present invention pertains to an antiviral drug for severe fever with thrombocytopenia syndrome, which contains a compound represented by formula (I) or a salt thereof, or a solvate of the compound or salt (In the formula, R1 and R2 are the same or different from each other, and each represents a substituted or unsubstituted C1-10 alkyl group, R1 and R2 may form a substituted or unsubstituted 5- or 6-member ring in conjunction with an adjacent nitrogen atom, and X represent a halogen atom.)
-
公开(公告)号：US10987372B2
公开(公告)日：2021-04-27
申请号：US16083762
申请日：2017-03-10
申请人： KAGOSHIMA UNIVERSITY , NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY , DAIKIN INDUSTRIES, LTD.
发明人： Masanori Ikeda , Midori Takeda , Masanori Baba , Nobuyuki Kato
IPC分类号： A61K31/7076 , A61P1/16 , A61P31/20 , A61P31/14 , A61P35/00
摘要： It is an object of the present invention to provide a novel therapeutic agent for hepatoma viruses. Specifically, the present invention relates to an anti-hepatoma virus agent, containing as an active ingredient a compound represented by the following Formula (I) or a pharmaceutically acceptable salt thereof: (wherein R1 is fluorine or hydrogen).
-
公开(公告)号：US11571416B2
公开(公告)日：2023-02-07
申请号：US16603907
申请日：2018-04-13
申请人： KAGOSHIMA UNIVERSITY
IPC分类号： A61K31/4706 , A61P31/14 , A61K31/4709 , A61K31/473 , A61K31/496 , A61K31/5377 , A61K31/541
摘要： Described herein are pharmaceutical compositions capable of blocking entry of a virus into a host cell and containing one or more compounds of the general formula I or a pharmaceutically acceptable derivative thereof and methods of treatment or prophylactic administration of these pharmaceutical compositions to treat viral infections.
-
-
搜索结果
3 条记录 (耗时 0.011 秒)
